Skip to main content
NSAG / Modules / M9 · Cannabis Healthcare Visibility
M9 Healthcare & Clinical

Cannabis Healthcare Visibility

The documentation gap between cannabis use prevalence and EHR documentation is 7:1. It is an institutional design problem rooted in how care systems are built, and it has specific, documentable patient safety consequences.

View Assessment Status → See the Evidence
The Governance Problem

Why This Module Exists

Lapham et al. (2022) published the verified primary source for the documentation gap: 35.1% of primary care patients reported implicit medical cannabis use; EHR documented rate was 4.8% — from the same patient population, measured simultaneously. Tavabi et al. (2023) found the gap tracks racial and socioeconomic lines independent of use prevalence: the populations most burdened by the gap are already facing the greatest healthcare equity challenges. Beiler et al. (2024) confirmed that documentation completeness depends on whether structured EHR fields exist, independent of patient willingness. The governance response focuses on institutional infrastructure and how systems are designed to document care.

Evidence Base

The Research Foundation

Lapham et al. (2022)
JAMA Network Open DOI →

35.1% vs. 4.8%. Verified 7:1 gap from the same patient population, measured simultaneously.

Tavabi et al. (2023)
npj Digital Medicine DOI →

370,087 patients. Documentation <2%. Racial and socioeconomic disparities independent of use prevalence.

Beiler et al. (2024)
JMIR Formative Research DOI →

Structured EHR fields produce 93.6% completion vs. 30.8% without. Documentation is infrastructure-dependent.

Six Governance Dimensions

What the Assessment Measures

The prototype organizes reflection across six proposed governance dimensions. It does not produce a validated institutional score, audit, accreditation, or certification.

1 Cannabis Screening Standards
2 Provider Training Standards
3 EHR Documentation Architecture
4 Disclosure Safety Infrastructure
5 Regulatory Compliance & Legal Review
6 Quality Improvement Integration
PIONEERING Governance

What the Highest Tier Looks Like

PIONEERING — Fully Implemented Governance

Validated cannabis screening at every patient contact (≥85% completion); all clinical providers trained in CYP450 interactions within 2 years; structured cannabis EHR fields (≥85% completion); written disclosure safety policy communicated in writing at intake; documented legal guidance updated within 3 years; cannabis documentation rate as quarterly QI metric.

The full tier operationalization — PIONEERING through EARLY STAGE, with specific observable criteria for all six dimensions — is documented in the Framework Foundation.

Who Should Prioritize This Module

Built for These Institutions — and the People Inside Them

Primary care practices · Hospitals and health systems · FQHCs · Community health organizations · Native Hawaiian and Pacific Islander health programs · Any institution where the service population includes cannabis users

And any patient whose cannabis use goes undocumented, and the clinician who needs to see it before prescribing.

Related Modules

What to Assess Next

M4 Cannabis Public Health Infrastructure M8 Burnout Recovery Infrastructure M11 Medical Technology & Evidence Standards

Review the M9 assessment prototype.

Review the module scope and proposed dimensions. The assessment remains an educational prototype; no email report or institutional finding is active.

View Assessment Status → Book a Discovery Call